ArticleMetabolic brain disease2026
FPR1 drives sepsis-associated cognitive impairment through region-specific transcriptional and splicing dysregulation in the brain.
Article in Metabolic brain disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Sepsis-associated encephalopathy (SAE) usually causes long-term cognitive impairment, which seriously compromises the quality of life of patients, but the precise molecular mechanisms have not been elucidated. Formyl peptide receptor 1 (FPR1), a G protein-coupled receptor, plays a pivotal role in systemic and neuroinflammatory responses, but its function in SAE is unclear. Here, we employed Fpr1 knockout mice subjected to cecal ligation puncture (CLP) to model sepsis, integrating behavioral tests, flow cytometry, and transcriptomic and alternative splicing analyses of the hippocampus and prefrontal cortex. Sepsis markedly induced the expansion of reactive myeloid cells and upregulated FPR1 expression. Fpr1 deletion improved cognitive function, attenuated neuroinflammation, enhanced survival, and reversed sepsis-induced downregulation of neuroprotective genes in the hippocampus and myelin-related genes in the prefrontal cortex. Moreover, Fpr1 loss corrected aberrant transcription and splicing events in a brain region-specific manner. Our findings demonstrate that FPR1 drives SAE by orchestrating region-specific transcriptional and splicing networks, providing a rationale for targeting FPR1 to treat post-sepsis cognitive dysfunction.
Indexed as
Identifiers
42803863What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.